Claudio Cuello, MD, D.Sc., FRSC, OC

Dr. Cuello has contributed to his field of research with pioneering publications on dendritic release of neurotransmitters, the localization and role of central and peripheral neuropeptides, trophic factor-induced repair and synaptogenesis and novel applications of monoclonal antibodies in the neurosciences. During his career he collaborated very closely with Drs. William F. Ganong, Leslie Iversen and Cesar Milstein.

Currently, he leads a research team working on multidisciplinary aspects (from molecular biology to cognition) of aging, models of Alzheimer’s disease neuropathology, inflammation, CNS degeneration/repair and experimental therapeutics of the AD-like amyloid pathology.

He has received numerous recognitions, such as the Heinz Lehman Award, the Novartis Award he was named Professor Honoris Causa in Buenos Aires Argentina, he also received the Chancellor’s Award in Neurosciences, from Louisiana State University and has been elected a Fellow of the Royal Society of Canada. For his contributions in the Neurosciences and biotechnology and his role in building a successful academic department he was inducted by the Governor General of Canada, as an Officer of the Order of Canada in May of 2010. In 2013 he received the Queen Elizabeth II Diamond Jubilee Medal from the Office of the Governor General of Canada. 1n 2015 he received the Raices prize by the Argentine Ministry of Science and Technology.

He maintains an active and successful research lab with close collaborations with leading labs of the UK, USA, Italy, Spain and Argentina. He is listed as a highly cited Neuroscientist by the Institute of Scientific Information, with over 26,000 citations, and his current H-Index is of 86 (Google Scholar)


 

Charles DeCarli, MD

Dr. Charles DeCarli is a Professor of Neurology at the University of California in Davis, California and recipient of the Victor and Genevieve Orsi Chair in Alzheimer’s Research.  He is the Director of the UC Davis Alzheimer’s Disease Center, a United States National Institutes of Health funded Alzheimer’s research center. He is also Director of the Imaging of Dementia and Aging (IDeA) laboratory.

His research focuses on using advanced structural and functional brain imaging to study normal aging, mild cognitive impairment and dementia and the role of genetics, cerebrovascular and Alzheimer’s disease on these processes.  He is a recipient of the J. Allyn Taylor International Prize in Medicine—Imaging of the Aging Brain in recognition of his work.


Katherine S. McGilton, RN, PhD, FAAN

Dr. McGilton is a Senior Scientist at the Toronto Rehabilitation Institute-University Health Network and Professor at the Lawrence S. Bloomberg Faculty of Nursing, University of Toronto. She is currently the co-lead of the Quality of Life Theme for the Canadian Consortium on Neurodegenerative Diseases in Aging (CCNA).

She has research funding as the principal investigator from the Canadian Institutes of Health Research (CIHR), Alzheimer Society of Canada and the Health Services Research Fund, MOH&LTC.  The focus of her is on enhancing the care of the older adult, especially those with dementia, through the development and application of interventions, outcome measures and models of care in practice. She also developed a model of care for rehabilitating complex patients post-hip fracture surgery, targeting patients with cognitive impairment that was subsequently evaluated in an investigator-initiated, multi-site clinical trial.


Mary Tierney, C. Psych, PhD

Dr. Tierney is Professor & Clinician Scientist in the Department of Family and Community Medicine at the University of Toronto, and is a Clinical Neuropsychologist and Director of the Primary Care Research Unit at Sunnybrook Health Sciences Centre. She also leads the Women, Gender, Sex and Dementia Program of the Canadian Consortium on Neurodegeneration in Aging.

The focus of her research is on neuropsychological aspects of dementia, including sex differences, early identification and differential diagnosis, and the care of older people with dementia. She is also interested in the role of estrogen in cognitive function throughout a women’s lifespan and factors that influence this including menopause, exercise, and the use of anti-estrogen therapy to treat breast cancer.


Kenneth Rockwood, MD, FRCPC, FRCP

Dr. Kenneth Rockwood is a professor of Medicine (Geriatric Medicine and Neurology) at Dalhousie University, and an active staff physician at the Queen Elizabeth II Health Sciences Centre. He is also the Dalhousie Medical Research Foundation Kathryn Allen Weldon Professor of Alzheimer Research at Dalhousie University. A native of Newfoundland, he received his MD from Memorial University, and completed internal medicine training at the University of Alberta and geriatric medicine at Dalhousie University.

A leading authority on frailty research, Kenneth Dr. Rockwood has more than 450 peer-reviewed publications and nine books to his credit, including the eighth edition of the Brocklehurst’s Textbook of Geriatric Medicine & Gerontology. He is a member of the Research Executive Committee of the Canadian Collaboration on Neurodegeneration in Aging, and leads the CCNA’s Quality of Life Theme, and the Knowledge Translation and Exchange Platform.


Tarun Dua, MD

Dr. Tarun Dua is currently working in the Department of Mental Health and Substance Abuse at World’s Health Organization Headquarters. She is the focal point for dementia in the organization and led the work on the WHO/ADI report in 2012 “Dementia: public health priority”; organization of First WHO Ministerial Conference on  Global Action Against Dementia, March 2015;  development of Global Dementia Observatory and now coordinating the implementation of the global action plan on public health response to dementia.

She has been involved in the development of the mhGAP Guidelines on mental, neurological and substance use disorders and the latest edition of Disease Control Priorities in Developing Countries’ volume on mental, neurological and substance use disorders (including dementia).


Carole A. Estabrooks, CM, PhD, RN, FCAHS, FAAN

Dr. Carole Estabrooks is Professor, Faculty of Nursing, at the University of Alberta, and a Tier 1 Canada Research Chair in Knowledge Translation. She is a Member of the Order of Canada (CM), a fellow in the Canadian Academy of Health Sciences (FCAHS) and a fellow in the American Academy of Nursing (FAAN). She is Scientific Director of the Knowledge Utilization Studies Program (KUSP) and the pan-Canadian Translating Research in Elder Care (TREC) program, both hosted at the University of Alberta.

Dr Estabrooks’ applied health services research program focuses on knowledge translation – she studies the influence of organizations on the use of knowledge and the effects of the organization on quality of care, quality of life/quality of end of life and quality of work life outcomes in frail and vulnerable older adults, most with dementia in the residential long term care sector. Increasingly, she focuses on quality improvement and the spread and scale-up of innovation in this sector. Dr. Estabrooks is a past member and vice-chair of CIHR’s Institute of Aging Advisory Board. She is appointed in the University of Alberta’s School of Public Health, and is affiliated with the University of Toronto’s Nursing Health Services Research Unit. She is a co-investigator on numerous national and international research projects. She is the 2014 recipient of the CIHR Institute of Aging’s Betty Havens prize in Knowledge Translation. She teaches in the doctoral program and supervises graduate students and postdoctoral fellows. She has developed and continues to evaluate the Alberta Context Tool (ACT) currently in use in nine countries and six languages.


Susan M. Resnick, Ph.D.

Dr. Resnick received her Ph.D. in Differential Psychology and Behavioral Genetics from the University of Minnesota and completed a postdoctoral fellowship in Neuropsychology and Neuroimaging at the University of Pennsylvania. She was Research Assistant Professor of Psychology in Psychiatry at the University of Pennsylvania prior to joining the Intramural Research Program of the NIA in 1992.

She is currently Chief of the Laboratory of Behavioral Neuroscience and the Brain Aging and Behavior Section at the NIA. Dr. Resnick studies cognitive and brain aging in health and disease, with a focus on early markers of cognitive impairment and Alzheimer’s disease. She is the lead investigator of the cognitive and brain imaging components of the Baltimore Longitudinal Study of Aging (BLSA) and the NIA Project Officer of the Women’s Health Initiative Memory Study (WHIMS) Suite of Studies. She also serves on the Steering Committee of The Testosterone Trials, and oversaw the recently published Cognitive Function Trial of the TTrials.


Pedro Rosa-Neto, MD, PhD

Dr. Pedro Rosa-Neto MD (Federal University Rio Grande do Sul, Brazil), PhD (Aarhus University PET Centre, Denmark) is an associate professor of Neurology, Neurosurgery and Psychiatry at McGill University, affiliated to the Douglas Research Centre. He is a Fonds de recherche du Québec – Santé Senior Scholar. He is the Chair and National Coordinator of PET of the CIHR-Canadian Consortium on Neurodegeneration in Aging (CCNA) and vice chair of CCNA’s Team 2 “Inflammation and Trophic Factor deregulation in Alzheimer’s disease”.

Dr. Rosa-Neto directs McGill University’s Research Centre for Studies in Aging and the laboratory for translational neuroimaging. Dr. Rosa-Neto’s research focuses on methodological aspects of amyloid, tau and neuroinflammation imaging in the context of clinical trials. Dr. Rosa-Neto conducts research on new treatments to prevent and treat dementia symptoms at the McGill Alzheimer’s disease research Unit.

He is a neurologist specialized in dementia with expertise in quantification of brain function using imaging techniques, in particular Positron Emission Tomography (PET). He directs the Atypical Dementia Clinic at the Douglas Hospital. He was a committee member of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4).

Dr. Rosa-Neto’s research is funded by Alzheimer’s Association USA, Canadian Foundation for Innovation (CFI), Fonds de recherche du Québec – Santé (FRQS), Brain Canada, Canadian Institutes of Health Research (CIHR) and the Weston Brain Institute.


Debra Morgan, PhD, RN, FCAHS

Dr. Morgan is Professor and Chair of Rural Health Delivery at the Canadian Centre for Health and Safety in Agriculture, University of Saskatchewan, where she leads the Rural Dementia Action Research (RaDAR) team. She leads the rural stream of Team 20 (Issues in Dementia Care in Rural and Indigenous Dementia Care) of the Canadian Consortium in Neurodegeneration in Aging (CCNA).

Her research focuses on improving health service delivery for individuals with dementia and their formal and informal caregivers in rural settings. Her research focuses on improving health service delivery for individuals with dementia and their formal and informal caregivers in rural settings.


 

Neil Cashman, MD

Dr. Neil Cashman is a neurologist-neuroscientist working in neurodegeneration and neuroimmunology. His special areas of work are the motor neuron diseases, particularly amyotrophic lateral sclerosis, and the amyloid encephalopathies, including prion illnesses and Alzheimer’s disease. He is Professor of Medicine at the University of British Columbia, where he holds the Canada Research Chair in Neurodegeneration and Protein Misfolding Diseases.

He is Founder and Chief Scientific Officer of ProMIS Neurosciences in Toronto. Special honors include the Jonas Salk Prize for “a lifetime of outstanding contributions to basic biomedical research,” his Tier 1 Canada Research Chair in at the UBC (2005-2018), election to the Canadian Academy of Health Sciences in 2008, and Genome BC award for Scientific Excellence in 2012.


 

Yves Joanette, PhD, FCAHS

Yves Joanette is a Professor of Cognitive Neurosciences and Aging for the Faculty of Medicine at the Université de Montréal. He is currently the Scientific Director of the Institute of Aging of the Canadian Institutes of Health Research (CIHR). He is the scientific lead of the CIHR Dementia Research Strategy and acts as a co-lead of other CIHR initiatives on eHealth Innovations and on Healthy and Productive Work. Yves Joanette also co-leads the CIHR Canadian Longitudinal Study on Aging. He sits on many international advisory and management boards, including The EU Joint Programme – Neurodegenerative Disease Research (JPND) and two other European initiatives in which Canada participates. Yves Joanette is currently the Chair of the World Dementia Council.

Yves Joanette was a Scholar and Scientist of the Canadian Medical Research Council and has received many distinctions, including the André-Dupont Award, and the Eve Kassirer Award for Outstanding Professional Achievement. Yves Joanette is a Fellow of the Canadian Academy of Health Sciences. The Université Lumière de Lyon (France) and the University of Ottawa (Canada) both presented him with an Honorary Doctorate.


Pierre Bellec, PhD

Dr. Pierre Bellec is the co-leader of the biomarkers team of the Canadian Consortium on Neurodegeneration in aging, together with Dr. Roger Dixon. Dr. Bellec received a MSc in mathematics in 2002, and a PhD in medical imaging (physics), from Université Paris XI Orsay in 2006. He was a post-doctoral fellow at the Montreal Neurological Institute, McGill University in 2006-10. He started the laboratory for brain simulation and exploration (SIMEXP) in 2010, at the Centre de recherche de l’institut de gériatrie de Montréal (CRIUGM). He is also an assistant professor at the department of computer science and operations research, Université de Montréal. The SIMEXP laboratory is developing machine learning tools to study the brain structure and function using magnetic resonance imaging.

These tools are used to explore the processes of brain reorganization in healthy aging and neurodegenerative diseases. SIMEXP is also working on neuroimaging simulations for the evaluation and validation of neuroimaging analysis methods. Dr Bellec is involved in several data sharing initiatives and open source software development projects. He co-founded the brainhack workshop series as well as the special interest group on open science at the organization for human brain mapping, which he currently chairs. He is the interim director of the functional neuroimaging unit at CRIUGM and a “chercheur boursier Junior 2” scholar from Fonds de recherche du Québec.


Senator Kenneth K. Ogilvie, C.M., Ph.D., D.Sc., H.Col., F.C.I.C.

The Honourable Kelvin K. Ogilvie, C.M., Ph.D., D.Sc., H.Col., F.C.I.C ., Senator, was (1993–2003) President and Vice-Chancellor of Acadia University in Wolfville, Nova Scotia.
Senator Kelvin K. Ogilvie is a leading expert on biotechnology, bioorganic chemistry and genetic engineering. His scientific accomplishments include the development of the chemistry of the “Gene Machine”, an automated process for the manufacture of DNA. He is the inventor of Ganciclovir, a drug used worldwide to fight infections that occur when one’s immune system is weakened. Both of these achievements were recognized in 2000 as “Milestones of Canadian Chemistry in the 20th Century” by the Canadian Society of Chemistry.

He was named a Steacie Fellow in 1982
Admitted to the Order of Canada in 1991
In 1992 he received the Manning Principal Award as Canada’s outstanding contributor to innovation.
He was an inaugural inductee into the Nova Scotia Discovery Centre Science and Technology Hall of Fame in 2002.
Dr. Ogilvie was inducted into the Canadian Science and Engineering Hall of Fame in Ottawa in November, 2011.
In 2013 he received the Rx&D Health Research Foundation Medal of Honour for his outstanding contributions to health sciences and public health innovation.
Dr. Ogilvie was appointed to the Canadian Senate by Prime Minister Stephen Harper on August 27th, 2009. He is currently the Chair of the Senate Standing Committee on Social Affairs, Science and Technology and Past Chair of the Health Research Caucus.
____________________________________________________________
Current Member of the following Senate committees:
Agriculture and Forestry (2010-Present)
Rules, Procedures and the Rights of Parliament (2009-2011; 2015-Present)
Social Affairs, Science and Technology
(Member: 2009; Vice Chair: 2010-2011; Chair: 2011-Present)


Peter St George-Hyslop, MD, FRS, FRSC, FRCPC

Peter St George-Hyslop is the acclaimed director of the Tanz Centre for Research in Neurodegenerative Disease and a professor in the University of Toronto’s Division of Neurology. He received his M.D. from the University of Ottawa, specialized in internal medicine and neurology and conducted postdoctoral research at the University of Toronto and at Harvard Medical School.
Prof. St George-Hyslop was an instructor in neurology and genetics at Harvard University and assistant physician in the Departments of Neurology and Genetics at Massachusetts General Hospital before assuming his current position at the University of Toronto in 1991, where now he holds the rank of University Professor, the University’s highest academic post.

Dr. St George-Hyslop’s honours include the Francis A. McNaughton Prize from the Canadian Neurological Society and the Award for Medical Research from the Metropolitan Life Foundation. He was a Medical Research Council of Canada (now the Canadian Institutes of Health Research) Scholar in 1991 and a Distinguished Scientist in 2000. He received the Gold Medal in Medicine from the Royal College of Physicians of Canada in 1994 and the Michael Smith Award from the Canadian Institutes of Health Research in 1997. In 1995, he became a member of the American Society for Clinical Investigation, and he is a fellow of the Royal Society of Canada. In 2004 he was awarded the Oon International Award in Preventive Medicine from the University of Cambridge, and in 2007 he was elected as a foreign member to the Institute of Medicine of the National Academy of Sciences.  Dr. St George Hyslop is a Howard Hughes International Scholar, Fellow of the Royal Society of London. He was awarded the BIAL Merit Award in Medical Sciences in and was named a Fellow of the American Neurological Association also in 2013. He was awarded the Dan David Prize in 2014.